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Introduction 
 
Hereditary non-syndromic hearing loss (HL) is 
the most common defect that attributed to both 
genetical and environmental factors and has an 
incidence of 1 in 500 infants (1). HL is extremely 
heterogeneous defect and up to date, about 62 
genes have been identified for autosomal reces-
sive non-syndromic hearing loss (ARNSHL) (2). 
More than thousands mutations in more than 60 
genes have been identified which associate with 
HL (2), however, most of HL causes and their 
mutation is still unknown. One group of genes 
associated with HL is Myosin. Myosins are a su-
perfamily consisting of more than 35 classes and 
they are actin-based molecular motors (3). N-
terminal region of myosin heavy chain consists of 
highly conserved sequences and its head domain 
following a divergent neck domain. N-terminal 
region of head domain binds to actin and ATP 
(4). C-terminal region of Myosin is known as tail 
domain and in various classes of Myosin is highly 
divergent. Myosins are mainly classified to con-
ventional and unconventional (5). Myosin VIIA 
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(MYO7A) belongs to unconventional myosins, 
has 49 exons, and mostly is expressed in inner ear 
and retina (6). MYO7A is made in inner eye and 
contribute to organization of the stereocilia in the 
hair bundles. 
Up to now, 340 different mutations and more 
than 248 protein variants in MYO7A associated 
with these disorders have been reported (7) 
(http://www.umd.be -/MYO7A/) that affect the 
head and tail domains (7). Defects in MYO7A are 
cause of syndromic (USH1B) and nonsyndromic 
deafness (two form of dominant (DFNA11) and 
recessive (DFNB2) deafness) (7, 8). Mutations in 
the head domain are thought to affect MYO7A 
motor function, but there is little known about 
the affect protein function when mutations in the 
tail domain (8). This present study aimed to de-
termine mutation frequency in MYO7A and lin-
kage analysis of DFNB2 locus. 
 
Materials and Methods 
 
Subjects and Sampling 
The Institutional Review Boards of Tehran Uni-
versity of Medical Sciences and Shahrekord Uni-
versity of Medical Sciences approved this descrip-
tive laboratory study in 2014.  
Thirty families (405 individual) including 158 af-
fected individuals of clients of state welfare or-
ganization and exceptional children education 
organization from Hamedan and Kohgiluyeh and 
Boyer-Ahmad provinces in the west of Iran were 
included in this study. Families investigated had 
at least two affected children. Parents were unaf-
fected and majority of them had consanguineous 
marriages. All patients underwent audiogram 
hearing test and ear, nose and throat (ENT) spe-
cialist confirmed presence of HL in patients. All 
families were informed and written consent was 
obtained. Then 5 cc peripheral blood in tubes 
containing 0.5 M EDTA from all available mem-
bers of all families were captured.  
 
DNA extraction 
Genomic DNA was extracted from blood sam-
ples using phenol-chloroform standard method 
(9). DNA quality (UNICO 2100, USA) and on 
0.5% agarose gel stained with 0.5 x gel red (10).  
 
STR (Short tandem repeats) marker genotyp-
ing and linkage analysis 
For analyzing of locus, four different STR markers 
were used. Upon encountering an uninformative 
marker, further markers were examined. In Table 
1, used markers and their characteristics are 
shown.  
The criteria for selecting these markers are as fol-
lowing greater heterozygosity values, shorter 
fragments in length and lying close to the known 
locus. 
 
Table 1: STR marker used in study and their characteristics 
 
STR 
marker 
Physical 
position 
HZ (%) 
 
Amplicon 
Size 
Forward Primer Reverse Primer 
D11S4179 76,396,260 - 
76,396,495 
72 200-256 GGATGTAAGAGTAACTGGCTCCG GAAAATGTTCTGCCTGAGGG 
D11S4186 76,968,518 - 
76,968,685 
79 154-175 ATTCTCCCAATCTATCGCTC GGGCAGTAATGATGATGTG 
D11S4079 77,119,447 - 
77,119,701 
75 217-265 CAGCAAGATCCTGTCTCAA CTCCTTAAAGTGGGGGAGTT 
D11S911 77,448,583 - 
77,448,769 
85 159-203 CTTCTCATGCTTGACCATTT CTTCTGAACAATTGCCACAT 
HZ: Heterozygous 
 
For S-Link and LOD score calculation, we used 
genetic software Easy linkage plus ver. 5.05 (11). 
For S-Link calculation, we used Fast Slink ver. 
2.51. Two-point and multipoint parametric LOD 
scores were calculated by Super link ver. 1.6, 
Gene hunter ver. 2.91, respectively. For LOD 
Iran J Public Health, Vol. 46, No.1, Jan 2017, pp.76-82  
 
78                                                                                                          Available at:    http://ijph.tums.ac.ir  
score calculations using this software, inheritance 
pattern of autosomal recessive, complete pene-
trance and disease allele frequency of 0.001 were 
assumed. Haplopainter ver. 029.5 software was 
used for reconstruction of haplotypes (12). Nega-
tive subjects for connexin 26 gene mutation are 
selected for linkage analysis. STR markers were 
selected based on their physical distance found at 
NCBI Uni STS. For markers Primers, NCBI Map 
Viewer is used and Touchdown program is used 
for markers.  
 
Mutation screening of MYO7A 
In order to analyze the mutation in families 
linked to mentioned locus, for 49 exons, intron-
exon boundaries, primers were designed by Oligo 
ver. 6.7.1.0 (National Biosciences Inc., Plymouth, 
MN, USA) and Primer3 software 
(http://www.genome.wi.mit.edu/cgi-
bin/primer/primer3_www.cgi). Thermal cycling 
conditions for amplifying exons were as follows: 
95 °C for primary denaturation for 5 min, 8 
touchdown cycles of 94 °C denaturation of DNA 
strands for 30 sec, 55 °C to 62 °C annealing tem-
perature for 30 sec, 72 °C extension for 30 sec 
and in next 25 cycles of 94 °C denaturation for 
30 sec, 54 °C annealing temperature for 30 sec, 
72 °C extension for 30 sec and 72 °C final exten-
sion for 5 min. In each PCR , 0.5 μl of each pri-
mers (10 PM), 0.5 μl dNTP mix (10 mM), 1 μl 
MgCl2 (50 mM), 0.1 μl Taq polymerase (5 
unit/μl), 2 μl genomic DNA (50 ng). The total 
volume was adjusted to 25 μl by ddH2O. After 
amplifying desired piece of DNA, PCR product 
for each family separately was run in 8-12% po-
lyacrylamide gel electrophoresis at 35-40 mA for 
3 h, following silver staining of the gel, bands 
were visualized. DNA sequencing of the PCR- 
products was performed bi-directionally on an 
ABI 3730XL automated sequencer (Applied Bio-
systems, Macrogen and, Seoul, Korea) than any 
variant in this gene sequence using Seqmqn soft-
ware analyzer and Chromas software 
http://www.technelysium.com.au/chromas.html 
were detected. 
 
Results 
 
Majority of studied subjects showed severe to 
profound bilateral neurosensory HL. Seventy 
percent of investigated families in present study 
were consanguineous families. Based on 
information given in pedigree, type of HL was 
autosomal recessive. Among the investigated 
families, two families displayed linkage to 
DNFB2 locus and by analysis of MYO7A gene 
two mutations have been detected. Estimated 
maximum Slink for these 30 families ranged from 
1.12 to 7.68, two-point and multipoint LOD and 
S-link scores related to two families are indicated 
in Table 2. 
 
Table 2: S-Link and LOD scores calculated for family linked to DFNB3 
 
Family S-LINK Two point LOD score Multipoint LOD score 
Family- 13 2.53 1.96 2.30 
Family -32 2.53 3.2 1.3 
 
Family-13: This family was from Hamedan prov-
ince (Fig. 1) and after sequencing of MYO7A 
gene, homozygous missense mutation c.6487 
G>A was found in exon 48 that result in an 
amino acid substitution (p.G2163S) in C-
terminal FERM (F for 4.1 protein, E for ezrin, R 
for radixin and M for moesin) domain of the 
myosin VIIA protein (Fig. 2). This Mutation in 
parents and non-affected children was in hetero-
zygous state and parents had consanguineous 
marriage. Onset of hearing loss was prelingual 
and the progress of HL was unchanged, audio-
gram-hearing test confirmed the type of severe to 
profound. 
Family-32: This family was from Kohgiluyeh and 
Boyer-Ahmad province and consanguineous 
marriage was three grade (Fig. 3). 
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Fig. 1: pedigree and Haplotype of Family-13 
 
 
 
Fig. 2: Chromatograms results of MYO7A mutation in Family-13. A: normal alleles for c.6487 G>A. B: mutant al-
lele of c.6487 G>A. 
 
Affected individuals in this family showed pro-
found hearing loss along with progressive retinitis 
pigmentosa and vestibular dysfunction. Men-
tioned clinical signs and symptoms may suggest 
presence of USHB1. By sequencing of MYO7A 
gene, homozygous nonsense mutation (c.448 
C>T) in exon five was detected (Fig. 4) that re-
sulting in a premature truncation at amino acid 
position 150 (p.Arg150X) in the motor domain 
of this protein. 
Discussion  
 
In this study, 30 families with at least two af-
fected subjects from provinces of Hamedan and 
Kohgiluyeh and Boyer-Ahmad were investigated. 
Linkage analysis and haplotype analysis of STR 
molecular markers in DFNB2 locus for families 
with no mutation in connexin 26 were carried 
out. Since mutation in connexin 26 is responsible 
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for 18.29% of hearing loss in consanguineous 
families (13) and hearing loss is highly heteroge-
neous and due to presence of different ethnic 
groups (14) and high rate of consanguineous 
marriages in Iran, analysis of other loci associated 
with hearing loss in different populations of Iran 
is necessary (15-17).   
 
 
 
Fig. 3: Pedigree and Haplotype of Family-32 
 
 
 
Fig. 4: Chromatograms results of MYO7A mutation in Family-32. A: normal alleles for c.448 C>T. B: mutant allele 
of c.448 C>T. 
 
Thus, by analysis of families with no mutation in 
connexin 26 and other genes associated with HL. 
We can gain new insight into frequency of these 
genes. In this investigation, two families were 
found to be linked to DFNB2 locus. After se-
quencing of MYO7A gene, 2 variants c.448C>T 
in  Motor domain  and c.6487 G>A  in the C-
terminal FERM2 domain of MYO7A have been 
identified. 
MYO7A gene (NM_000260.3) is consisting of 49 
exons that encode a protein with 2215 amino ac-
ids. Up to date, majority of mutations identified 
in MYO7A were associated with ARNSHL and 
Usher syndrome and few number of these muta-
tions were associated with ADNSHL (DFNB11) 
(6). These mutations mostly cause loss of protein 
function. DFNB2 locus in one Tunisian family 
with non-syndromic hearing loss was mapped 
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(18), and up to date mutations in MYO7A in pa-
tients with hearing loss from different popula-
tions such as China (19), Tunisia (20), Pakistan 
(21), Taiwan (22) and Iran have been reported 
(23). One of identified mutations in this study is 
c.448C>T which is nonsense and changes argi-
nine amino acid in protein at position 150 for 
stop codon (p.Arg150X), this mutation occurs in 
motor domain of Myosin VII protein. The motor 
domain contains actin- binding domain and 
thought to be involved in mechanical movement 
of hair bundles using ATP, mutation in this pro-
tein binding site results in loss of function of ac-
tin protein and as a result, action cannot bind to 
the site and consequently cannot have normal 
movements. This mutation was first reported in 
patients with Usher syndrome that caused an ab-
normal protein near ATP binding site (24, 25). 
Based on clinical examination of patients, this 
study may suggest the presence of Usher syn-
drome type I. 
Mutation c.6487 G>A converts glycine amino 
acid to serine at position 2163 (Gly2163Ser). This 
mutation occurs in C-terminal FERM2 domain of 
protein interacts with specific proteins and con-
fers specificity to Myosin VIIA and mutations in 
this domain results in protein instability and im-
pairment in binding of other proteins to tail do-
main. This mutation was first in one Palestinian 
family and then later in one Iranian family was 
reported (21, 26). After sequencing of MYO7A 
gene, this mutation was attributed to cause of 
hearing loss in family-13. 
Mutation frequency of MYO7A gene in different 
populations of Iran as well as cause of hearing 
loss in most cases are still unknown and more 
extensive studies have to be done. 
 
Conclusion 
 
The mutation analysis of MYO7A gene led to the 
identification of two mutations in two families 
including missense mutations in different regions 
of the myosin-XV protein. MYO7A mutational 
frequency displayed of 6.67% in our cohort of 
deaf Iranian families.  
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